The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer

Manel B Hammouda1, Amy E Ford1, Yuan Liu1

  • 1Department of Dermatology, Duke University Medical Center, Durham, NC 27710, USA.

Cells
|April 8, 2020
PubMed

Insights

This review explores c-Jun N-terminal kinases (JNKs) and their role in skin conditions like psoriasis and skin cancers. Understanding JNK pathways is key for immune disorders and cancer research.

Area of Science:

  • Molecular Biology
  • Dermatology
  • Immunology

Background:

  • c-Jun N-terminal kinases (JNKs), a subfamily of mitogen-activated protein kinases (MAPK), regulate critical cellular functions.
  • JNK signaling pathways are implicated in cell proliferation, differentiation, survival, apoptosis, and inflammation.
  • Aberrant JNK pathway activity is linked to various immune disorders and cancers.

Purpose of the Study:

  • To review the roles of JNK proteins (JNK1, JNK2, JNK3) in common skin disorders.
  • To examine upstream regulators and downstream effectors of JNK signaling in dermatological conditions.
  • To consolidate current knowledge on JNK involvement in psoriasis, dermal fibrosis, scleroderma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and melanoma.

Main Methods:

  • Literature review of JNK signaling in skin biology and disease.
  • Analysis of studies focusing on JNK pathway components in specific dermatological conditions.
  • Synthesis of information on JNK regulators and effectors relevant to skin disorders.

Main Results:

  • JNK pathway dysregulation is a common feature in inflammatory skin diseases like psoriasis and fibrotic conditions such as scleroderma.
  • JNK signaling plays a significant role in the pathogenesis of skin cancers, including BCC, SCC, and melanoma.
  • Specific upstream activators and downstream targets of JNK have been identified in various skin pathologies.

Conclusions:

  • JNK proteins are crucial mediators in the development and progression of numerous skin disorders.
  • Targeting the JNK pathway presents a potential therapeutic strategy for treating inflammatory and oncogenic skin conditions.
  • Further research into JNK signaling mechanisms can uncover novel diagnostic and therapeutic targets for dermatological diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.5K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.7K